[D13]-DLin-MC3-DMA

DLin-MC3-DMA is a cationic lipid for siRNA mRNA, and vaccine delivery. Administration of DLin-MC3-DMA-based LNPs have delivered siRNA to reduced Factor VII levels or leukemic burden in mice. DLin-MC3-DMA can form nanoparticles that can encapsulate and deliver siRNA, mRNA, DNA, or small molecules into the cytoplasm and represent the most advanced delivery platforms for the systemic administration of active molecules.

Nucleosyn provides custom stable isotope lipids to support dedicated projects, such as therapeutic drug monitoring thanks to mass spectrometry.